Monitoring risk and preventing ischemic stroke in the very old

References

• Lindley RI. Stroke prevention in the very elderly. Stroke. 2018;49(3):796–802. doi: 10.1161/STROKEAHA.117.017952
   PubMed Web of Science ®Google Scholar
• Yousufuddin M, Young N. Aging and ischemic stroke. Aging. 2019;11(9):2542–2544. doi: 10.18632/aging.101931
   PubMedGoogle Scholar
• Bushnell CD, Colón-Emeric CS. Secondary stroke prevention strategies for the oldest patients: possibilities and challenges. Drugs Aging. 2009;26(3):209–230. doi: 10.2165/00002512-200926030-00003
   PubMed Web of Science ®Google Scholar
• Kannan A, Delgardo M, Pennington-FitzGerald W, et al. Pharmacological management of cerebral ischemia in the elderly. Expert Opin Pharmacother. 2021;22(7):897–906. doi: 10.1080/14656566.2020.1856815
   PubMed Web of Science ®Google Scholar
• Navis A, Garcia-Santibanez R, Skliut M. Epidemiology and outcomes of ischemic stroke and transient ischemic attack in the adult and geriatric population. J Stroke Cerebrovasc Dis. 2019;28:84–89.
   PubMed Web of Science ®Google Scholar
• Smithard DG. Stroke in frail older people. Geriatrics. 2017;2:24. InternetAvailable from. doi: 10.3390/geriatrics2030024
   PubMedGoogle Scholar
• Denti L, Agosti M, Franceschini M. Outcome predictors of rehabilitation for first stroke in the elderly. Eur J Phys Rehabil Med. 2008;44:3–11.
   PubMed Web of Science ®Google Scholar
• Pohjasvaara T, Erkinjuntti T, Vataja R, et al. Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years. Stroke. 1997;28(4):729–735. doi: 10.1161/01.STR.28.4.729
   PubMed Web of Science ®Google Scholar
• Arboix A, García-Eroles L, Massons J, et al. Lacunar infarcts in patients aged 85 years and older. Acta Neurol Scand. 2000;101(1):25–29. doi: 10.1034/j.1600-0404.2000.00005.x
   PubMed Web of Science ®Google Scholar
• Rojas JI, Zurrú MC, Romano M, et al. Acute ischemic stroke and transient ischemic attack in the very old - risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol. 2007;14(8):895–899. doi: 10.1111/j.1468-1331.2007.01841.x
   PubMed Web of Science ®Google Scholar
• Imahori T, Tanaka K, Arai A, et al. Mechanical thrombectomy for acute ischemic stroke patients aged 80 years or older. J Stroke Cerebrovasc Dis. 2017;26(12):2793–2799. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.060
   PubMed Web of Science ®Google Scholar
• Bentsen L, Christensen L, Christensen A, et al. Outcome and risk factors presented in old patients above 80 years of age versus younger patients after ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(7):1944–1948. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.002
   PubMed Web of Science ®Google Scholar
• González Hernández A, Pi Ó F, López Fernández J C, et al. Factores de riesgo, etiología y pronóstico en pacientes mayores de 80 años con accidente cerebrovascular. Rev Esp Geriatr Gerontol. 2008;43:366–369. doi: 10.1016/S0211-139X(08)75192-8
   PubMedGoogle Scholar
• Cha J-K, Lim J-H, Kim D-H, et al. Prognostic factors for long-term poor outcomes after acute ischemic stroke in very old age (>80 years) patients: Total cholesterol level might differently influence long-term outcomes after acute ischemic stroke at ages above 80 years. Geriatr Gerontol Int. 2015;15:1227–1233. doi: 10.1111/ggi.12419
   PubMed Web of Science ®Google Scholar
• Takayanagi S, Ochi T, Hanakita S, et al. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era. Neurol Med Chir (Tokyo). 2014;54:435–440. doi: 10.2176/nmc.oa.2013-0264
   PubMed Web of Science ®Google Scholar
• Naess H, Gjerde G, Waje-Andreassen U. Ischemic stroke in patients older and younger than 80 years. Acta Neurol Scand. 2014;129(6):399–404. doi: 10.1111/ane.12199
   PubMed Web of Science ®Google Scholar
• Pastuszak Ż, Koźniewska E, Stępień A, et al. Importance rating of risk factors of ischemic stroke in patients over 85 years old in the polish population. Neurol Neurochir Pol. 2018;52(1):88–93. doi: 10.1016/j.pjnns.2017.11.007
   PubMed Web of Science ®Google Scholar
• Cocho D, Yarleque S, Boltes A, et al. Clinical outcome of ischemic stroke in old patients versus oldest-old. J Stroke Cerebrovasc Dis. 2018;27(12):3657–3661. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.041
   PubMed Web of Science ®Google Scholar
• McDonough RV, Ospel JM, Campbell BCV, et al. Functional outcomes of patients ≥85 years with acute ischemic stroke following EVT: A HERMES substudy. Stroke. 2022;53(7):2220–2226. doi: 10.1161/STROKEAHA.121.037770
   PubMed Web of Science ®Google Scholar
• Jiao J, Liu S, Cui C, et al. Endovascular thrombectomy for acute ischemic stroke in elderly patients with atrial fibrillation. BMC neurol. 2022;22:1–9. Available from: http://doi.org/10.1186/s12883-022-02631-3
   PubMed Web of Science ®Google Scholar
• Kleine JF, Boeckh-Behrens T, Prothmann S, et al. Discrepancy between early neurological course and mid-term outcome in older stroke patients after mechanical thrombectomy. J Neurointerv Surg. 2016;8(7):671–676. doi: 10.1136/neurintsurg-2015-011702
   PubMed Web of Science ®Google Scholar
• Marini C, Baldassarre M, Russo T, et al. Burden of first-ever ischemic stroke in the oldest old: Evidence from a population-based study. Neurology. 2004;62(1):77–81. doi: 10.1212/01.WNL.0000101461.61501.65
   PubMed Web of Science ®Google Scholar
• Chen Y, Li C-H, Wang Y-X, et al. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in 80 years and older acute ischemic stroke patients. Cell Biochem Biophys. 2015;72(3):883–888. doi: 10.1007/s12013-015-0556-1
   PubMed Web of Science ®Google Scholar
• Wang Y, Jing J, Pan Y, et al. Clinical characteristics and prognosis in oldest old patients with ischaemic stroke or transient ischaemic attack in China. Ann Palliat Med. 2022;11(7):2215–2224. doi: 10.21037/apm-21-2830
   PubMed Web of Science ®Google Scholar
• Ford GA, Ahmed N, Azevedo E, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke. 2010;41(11):2568–2574. doi: 10.1161/STROKEAHA.110.581884
   PubMed Web of Science ®Google Scholar
• Berrouschot J, Rther J, Glahn J, et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients. Stroke. 2005;36(11):2421–2425. doi: 10.1161/01.STR.0000185696.73938.e0
   PubMed Web of Science ®Google Scholar
• Lee M, Huang W-Y, Weng H-H, et al. First-ever ischemic stroke in very old Asians: Clinical features, stroke subtypes, risk factors and outcome. Eur Neurol. 2007;58(1):44–48. doi: 10.1159/000102166
   PubMed Web of Science ®Google Scholar
• Lu W-H, Wen Y-W, Chen L-K, et al. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ. 2015;187(4):E130–E137. doi: 10.1503/cmaj.141219
   PubMed Web of Science ®Google Scholar
• Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30(2):103–112. doi: 10.1007/s40266-012-0044-x
   PubMed Web of Science ®Google Scholar
• Voeks JH, Howard G, Roubin G, et al. Mediators of the age effect in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Stroke. 2015;46(10):2868–2873. doi: 10.1161/STROKEAHA.115.009516
   PubMed Web of Science ®Google Scholar
• Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162:2333–2341. doi: 10.1001/archinte.162.20.2333
   PubMed Web of Science ®Google Scholar
• Mok V, Kim JS. Prevention and management of cerebral small vessel disease. J Stroke. 2015;17(2):111–122. doi: 10.5853/jos.2015.17.2.111
   PubMed Web of Science ®Google Scholar
• Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, et al. Cerebral small vessel disease: A review. Adv Clin Exp Med. 2021;30(3):349–356. doi: 10.17219/acem/131216
   PubMed Web of Science ®Google Scholar
• Pan D, Rong X, Li H, et al. Anti-platelet therapy is associated with lower risk of dementia in patients with cerebral small vessel disease. Front Aging Neurosci. 2022;14. InternetAvailable from.
   Web of Science ®Google Scholar
• Muller M, Sigurdsson S, Kjartansson O, et al. Joint effect of mid- and late-life blood pressure on the brain: the AGES-Reykjavik study. Neurology. 2014;82(24):2187–2195. doi: 10.1212/WNL.0000000000000517
   PubMed Web of Science ®Google Scholar
• O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–123. doi: 10.1016/S0140-6736(10)60834-3
   PubMed Web of Science ®Google Scholar
• Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28(7):1366–1372. doi: 10.1097/HJH.0b013e328339f9c5
   PubMed Web of Science ®Google Scholar
• Won CW, Kim S. Use of frailty in deciding clinical treatment goals for chronic disease in elderly patients in the community. J Am Med Dir Assoc. 2016;17(11):967–969. doi: 10.1016/j.jamda.2016.07.019
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–1898. doi: 10.1056/NEJMoa0801369
   PubMed Web of Science ®Google Scholar
• Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78. doi: 10.1186/s12916-015-0328-1
   PubMed Web of Science ®Google Scholar
• Pajewski NM, Williamson JD, Applegate WB, et al. Characterizing frailty status in the systolic blood pressure intervention trial. J Gerontol A Biol Sci Med Sci. 2016;71(5):649–655. doi: 10.1093/gerona/glv228
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281–1285. doi: 10.1016/0140-6736(91)92589-T
   PubMed Web of Science ®Google Scholar
• Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet. 1985;1:1349–1354. doi: 10.1016/S0140-6736(85)91783-0
   PubMed Web of Science ®Google Scholar
• Ho VS, Cenzer IS, Nguyen BT, et al. Time to benefit for stroke reduction after blood pressure treatment in older adults: A meta-analysis. J Am Geriatr Soc. 2022;70(5):1558–1568. doi: 10.1111/jgs.17684
   PubMed Web of Science ®Google Scholar
• Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350(9080):757–764. doi: 10.1016/S0140-6736(97)05381-6
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thijs L, Gasowski J, et al. Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial. Am J Cardiol. 1998;82:20R–22R. doi: 10.1016/S0002-9149(98)00752-8
   PubMed Web of Science ®Google Scholar
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP cooperative research group. JAMA. 1991;265(24):3255–3264. doi: 10.1001/jama.1991.03460240051027
   PubMed Web of Science ®Google Scholar
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–1041. doi: 10.1016/S0140-6736(01)06178-5
   PubMed Web of Science ®Google Scholar
• Tharmaratnam D, Karayiannis CC, Collyer TA, et al. Is blood pressure lowering in the very elderly with previous stroke associated with a higher risk of adverse events? J Am Heart Assoc. 2021;10(24):e022240. doi: 10.1161/JAHA.121.022240
   PubMed Web of Science ®Google Scholar
• Li L, Geraghty OC, Mehta Z, et al. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017;390(10093):490–499. doi: 10.1016/S0140-6736(17)30770-5
   PubMed Web of Science ®Google Scholar
• Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754–3832. doi: 10.1161/STR.0000000000000046
   PubMed Web of Science ®Google Scholar
• Yiin GSC, Howard DPJ, Paul NLM, et al. Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. J Neurol Neurosurg Psychiatry. 2017;88(1):12–18. doi: 10.1136/jnnp-2015-311947
   PubMed Web of Science ®Google Scholar
• Mant J, Hobbs FDR, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (The Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370(9586):493–503. doi: 10.1016/S0140-6736(07)61233-1
   PubMed Web of Science ®Google Scholar
• Ng KH, Shestakovska O, Connolly SJ, et al. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age Ageing. 2016;45(1):77–83. doi: 10.1093/ageing/afv156
   PubMed Web of Science ®Google Scholar
• Zathar Z, Karunatilleke A, Fawzy AM, et al. Atrial Fibrillation in Older People: Concepts and Controversies. Front Med. 2019;6:175. doi: 10.3389/fmed.2019.00175
   Web of Science ®Google Scholar
• Friberg L, Rosenqvist M, Lip GYH. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation. 2012;125(19):2298–2307. doi: 10.1161/CIRCULATIONAHA.111.055079
   PubMed Web of Science ®Google Scholar
• Edmiston MK, Lewis WR. Bleeding risk scores in atrial fibrillation: helpful or harmful? J Am Heart Assoc. 2018;7(18):e010582. doi: 10.1161/JAHA.118.010582
   PubMed Web of Science ®Google Scholar
• Melgaard L, Rasmussen LH, Skjøth F, et al. Age dependence of risk factors for stroke and death in young patients with atrial fibrillation: a nationwide study. Stroke. 2014;45(5):1331–1337. doi: 10.1161/STROKEAHA.114.004903
   PubMed Web of Science ®Google Scholar
• Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31(6):1240–1249. doi: 10.1161/01.STR.31.6.1240
   PubMed Web of Science ®Google Scholar
• Johnston SC, Elm JJ, Easton JD, et al. Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke. Circulation. 2019;140(8):658–664. doi: 10.1161/CIRCULATIONAHA.119.040713
   PubMed Web of Science ®Google Scholar
• Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes. Circulation. 2015;132(1):40–46. doi: 10.1161/CIRCULATIONAHA.114.014791
   PubMed Web of Science ®Google Scholar
• Ding L, Peng B. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis. Eur J Neurol. 2018;25(10):1276–1284. doi: 10.1111/ene.13695
   PubMed Web of Science ®Google Scholar
• Xie Y, Bowe B, Li T, et al. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans. BMJ Open. 2017;7(6):e015735. doi: 10.1136/bmjopen-2016-015735
   PubMed Web of Science ®Google Scholar
• Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195–2207. doi: 10.1056/NEJMoa0807646
   PubMed Web of Science ®Google Scholar
• Glynn RJ, Koenig W, Nordestgaard BG, et al. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152:488–496, W174. doi: 10.7326/0003-4819-152-8-201004200-00005
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–1630. doi: 10.1016/S0140-6736(02)11600-X
   PubMed Web of Science ®Google Scholar
• Mallery LH, Moorhouse P, McLean Veysey P, et al. Severely frail elderly patients do not need lipid-lowering drugs. Cleve Clin J Med. 2017;84(2):131–142. doi: 10.3949/ccjm.84a.15114
   PubMed Web of Science ®Google Scholar
• Afilalo J, Duque G, Steele R, et al. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol. 2008;51(1):37–45. doi: 10.1016/j.jacc.2007.06.063
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Zivin J, Breazna A, et al. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009;72(8):688–694. doi: 10.1212/01.wnl.0000327339.55844.1a
   PubMed Web of Science ®Google Scholar
• Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559.
   PubMed Web of Science ®Google Scholar
• Bonati LH, Kakkos S, Berkefeld J, et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021;6(2):I–XLVII. doi: 10.1177/23969873211012121
   Web of Science ®Google Scholar
• AbuRahma AF, Avgerinos ED, Chang RW, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg. 2022;75(1):4S–22S. doi: 10.1016/j.jvs.2021.04.073
   PubMed Web of Science ®Google Scholar
• Ballotta E, Toniato A, Da Roit A, et al. Carotid endarterectomy for asymptomatic carotid stenosis in the very elderly. J Vasc Surg. 2015;61(2):382–388. doi: 10.1016/j.jvs.2014.07.090
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361(9352):107–116. doi: 10.1016/S0140-6736(03)12228-3
   PubMed Web of Science ®Google Scholar
• Rajamani K, Kennedy KF, Ruggiero NJ, et al. Outcomes of carotid endarterectomy in the elderly: report from the national cardiovascular data registry. Stroke. 2013;44(4):1172–1174. doi: 10.1161/STROKEAHA.111.000513
   PubMed Web of Science ®Google Scholar
• Heo SH, Bushnell CD. Factors influencing decision making for carotid endarterectomy versus stenting in the very elderly. Front Neurol. 2017;8:220. doi: 10.3389/fneur.2017.00220
   PubMed Web of Science ®Google Scholar
• Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23. doi: 10.1056/NEJMoa0912321
   PubMed Web of Science ®Google Scholar
• Leung YYR, Bera K, Urriza Rodriguez D, et al. Safety of carotid endarterectomy for symptomatic stenosis by age: meta-analysis with individual patient data. Stroke. 2023;54(2):457–467. doi: 10.1161/STROKEAHA.122.040819
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Oh J, Fang J, et al. Urgency of carotid endarterectomy for secondary stroke prevention: results from the Registry of the Canadian Stroke Network. Stroke. 2009;40(8):2776–2782. doi: 10.1161/STROKEAHA.109.547497
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363(9413):915–924. doi: 10.1016/S0140-6736(04)15785-1
   PubMed Web of Science ®Google Scholar
• Kamtchum-Tatuene J, Jickling GC. Blood biomarkers for stroke diagnosis and management. Neuromolecular Med. 2019;21:344–368. doi: 10.1007/s12017-019-08530-0
   PubMed Web of Science ®Google Scholar
• Rozanski M, Waldschmidt C, Kunz A, et al. Glial fibrillary acidic protein for prehospital diagnosis of intracerebral hemorrhage. Cerebrovasc Dis. 2017;43(1–2):76–81. doi: 10.1159/000453460
   PubMed Web of Science ®Google Scholar
• Magenta A, Sileno S, D’Agostino M, et al. Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker. Clin Sci. 2018;132(22):2423–2436. doi: 10.1042/CS20180684
   Web of Science ®Google Scholar
• Driga MP, Catalin B, Olaru DG, et al. The need for new biomarkers to assist with stroke prevention and prediction of post-stroke therapy based on plasma-derived extracellular vesicles. Biomedicines. 2021;9(9):1226. doi: 10.3390/biomedicines9091226
   PubMed Web of Science ®Google Scholar
• Rist PM, Buring JE, Kase CS, et al. Healthy lifestyle and functional outcomes from stroke in women. Am j med. 2016;129(7):715–724.e2. doi: 10.1016/j.amjmed.2016.02.002
   PubMed Web of Science ®Google Scholar
• Kelly-Hayes M. Influence of age and health behaviors on stroke risk: lessons from longitudinal studies. J Am Geriatr Soc. 2010;58(2):S325–8. doi: 10.1111/j.1532-5415.2010.02915.x
   PubMedGoogle Scholar
• Ghozy S, Zayan AH, El-Qushayri AE, et al. Physical activity level and stroke risk in US population: A matched case-control study of 102,578 individuals. Ann Clin Transl Neurol. 2022;9:264–275.
   PubMed Web of Science ®Google Scholar
• Howard VJ, McDonnell MN. Physical activity in primary stroke prevention: just do it! Stroke. 2015;46(6):1735–1739. doi: 10.1161/STROKEAHA.115.006317
   PubMed Web of Science ®Google Scholar
• El-Hajj M, Salameh P, Rachidi S, et al. Adherence to the Mediterranean diet decreases the risk of stroke in the Lebanese population: a case-control study. Pharm Pract (Granada). 2021;19(1):2157. doi: 10.18549/PharmPract.2021.1.2157
   PubMed Web of Science ®Google Scholar
• Demarin V, Lisak M, Morović S. Mediterranean diet in healthy lifestyle and prevention of stroke. Acta Clin Croat. 2011;50:67–77.
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Brown RC, Davis TP. Smoking and ischemic stroke: a role for nicotine? Trends Pharmacol Sci. 2002;23(2):78–82. doi: 10.1016/S0165-6147(02)01893-X
   PubMed Web of Science ®Google Scholar
• Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther. 2010;8(7):917–932. doi: 10.1586/erc.10.56
   PubMedGoogle Scholar
• Gump BB, Matthews KA, Eberly LE, et al. Depressive symptoms and mortality in men: results from the multiple risk factor intervention trial. Stroke. 2005;36(1):98–102. doi: 10.1161/01.STR.0000149626.50127.d0
   PubMed Web of Science ®Google Scholar
• Larson SL, Owens PL, Ford D, et al. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke. 2001;32(9):1979–1983. doi: 10.1161/hs0901.094623
   PubMed Web of Science ®Google Scholar
• Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 2000;62(4):463–471. doi: 10.1097/00006842-200007000-00001
   PubMed Web of Science ®Google Scholar
• Wassertheil-Smoller S, Applegate WB, Berge K, et al. Change in depression as a precursor of cardiovascular events. Arch Intern Med. 1996;156:553–561. doi: 10.1001/archinte.1996.00440050111012
   PubMed Web of Science ®Google Scholar
• Colantonio A, Kasi SV, Ostfeld AM. Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. Am J Epidemiol. 1992;136:884–894. doi: 10.1093/aje/136.7.884
   PubMed Web of Science ®Google Scholar
• Salaycik KJ, Kelly-Hayes M, Beiser A, et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007;38(1):16–21. doi: 10.1161/01.STR.0000251695.39877.ca
   PubMed Web of Science ®Google Scholar
• Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–2388. doi: 10.1001/jama.2008.711
   PubMed Web of Science ®Google Scholar
• Eaker ED, Sullivan LM, Kelly-Hayes M, et al. Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med. 2007;69(6):509–513. doi: 10.1097/PSY.0b013e3180f62357
   PubMed Web of Science ®Google Scholar